Fabian Trillsch

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer

Xiaodan Meng, Volkmar Müller, Karin Milde‐Langosch et al. · Oncotarget · 2016 · 267 citations · Full text

Medicine, Cancer Biology, Oncology +16

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

Gerda Hofstetter, Nicole Concin, Radoslav Chekerov et al. · Gynecologic Oncology · 2013 · 135 citations

Medicine, Oncology, Surgery +11

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients

Xiaodan Meng, Simon A. Joosse, Volkmar Müller et al. · British Journal of Cancer · 2015 · 127 citations · Full text

Medicine, Gynecology, Oncology +15

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 114 citations

Medicine, Oncology, Pharmacotherapy +7

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +16